Gabexate [gabexát]
- Terms
-
gabexát-mesylát
gabexát-methansulfonát
gabexát-monomethansulfonát
gabexát-monomethansulfonát, značený C14
-
Foy
Gabexate Mesilate
Gabexate Mesylate
Gabexate Methanesulfonate
Gabexate Monomethanesulfonate
Gabexate Monomethanesulfonate, 14C-Labeled Cpd
A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
- DUI
- D016670 MeSH Browser
- CUI
- M0025401
- CAS
- Benzoic acid, 4-((6-((aminoiminomethyl)amino)-1-oxohexyl)oxy)-, ethyl ester
- Previous indexing
- Protease Inhibitors (1979-1989); Anticoagulants (1966-1991); Guanidines (1966-1991); Serine Proteinase Inhibitors (1990-1991)
- History note
- 92; was GABEXATE (NM) 1976-91
- Online note
- use GABEXATE (NM) to search GABEXATE 1979-91
- Public note
- 92; GABEXATE was indexed under GUANIDINES 1976-91
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine